Recent and future perspectives on engineering interferons and other cytokines as therapeutics
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent and future perspectives on engineering interferons and other cytokines as therapeutics
Authors
Keywords
-
Journal
TRENDS IN BIOCHEMICAL SCIENCES
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-10-12
DOI
10.1016/j.tibs.2022.09.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Facile discovery of surrogate cytokine agonists
- (2022) Michelle Yen et al. CELL
- Design of protein-binding proteins from the target structure alone
- (2022) Longxing Cao et al. NATURE
- Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor Regression
- (2022) Christopher J. Nirschl et al. Cancer Immunology Research
- Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker
- (2022) Aslan Mansurov et al. Nature Biomedical Engineering
- Challenges and advancements in the pharmacokinetic enhancement of therapeutic proteins
- (2021) Farnaz Khodabakhsh et al. PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY
- Long-Acting Human Interleukin 2 Bioconjugate Modified with Fatty Acids by Sortase A
- (2021) Mengxin Qian et al. BIOCONJUGATE CHEMISTRY
- Targeting IL-21 to tumor-reactive T cells enhances memory T cell responses and anti-PD-1 antibody therapy
- (2021) Ying Li et al. Nature Communications
- Structure-based decoupling of the pro- and anti-inflammatory functions of interleukin-10
- (2021) Robert A. Saxton et al. SCIENCE
- Preclinical Evaluation of Recombinant Human IL15 Protein Fused with Albumin Binding Domain on Anti-PD-L1 Immunotherapy Efficiency and Anti-Tumor Immunity in Colon Cancer and Melanoma
- (2021) Fei-Ting Hsu et al. Cancers
- Exploiting albumin as a mucosal vaccine chaperone for robust generation of lung-resident memory T cells
- (2021) Kavya Rakhra et al. Science Immunology
- Interferon-Based Biopharmaceuticals: Overview on the Production, Purification, and Formulation
- (2021) Leonor S. Castro et al. Vaccines
- An engineered IL-2 partial agonist promotes CD8+ T cell stemness
- (2021) Fei Mo et al. NATURE
- Accurate prediction of protein structures and interactions using a three-track neural network
- (2021) Minkyung Baek et al. SCIENCE
- Forms and Methods for Interferon’s Encapsulation
- (2021) Thelvia I. Ramos et al. Pharmaceutics
- De novo developed protein binders mimicking Interferon lambda signaling
- (2021) Lucie Kolářová et al. FEBS Journal
- Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistance
- (2021) Xuezhi Cao et al. Nature Communications
- VEGF-A, PDGF-BB and HB-EGF engineered for promiscuous super affinity to the extracellular matrix improve wound healing in a model of type 1 diabetes
- (2021) Michael J. V. White et al. npj Regenerative Medicine
- A C-terminal peptide from type I interferon protects the retina in a mouse model of autoimmune uveitis
- (2020) Chulbul M. Ahmed et al. PLoS One
- PASylation Enhances the Stability, Potency, and Plasma Half‐Life of Interferon α‐2a: A Molecular Dynamics Simulation
- (2020) Amir Shamloo et al. Biotechnology Journal
- Development and biological activity of long-acting recombinant human interferon-α2b
- (2020) Qian Zhang et al. BMC BIOTECHNOLOGY
- Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours
- (2020) Aslan Mansurov et al. Nature Biomedical Engineering
- Head-to-tail macrocyclization of albumin-binding domain fused interferon alpha improves the stability, activity, tumor penetration, and pharmacology
- (2020) Jianwen Guo et al. BIOMATERIALS
- IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
- (2020) Ting Zhou et al. NATURE
- Pegylated Engineered IL2 plus Anti–PD-1 Monoclonal Antibody: The Nectar Comes from the Combination
- (2020) Mathieu Rouanne et al. Cancer Discovery
- Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses
- (2020) Claire Gorby et al. Science Signaling
- Prolonged residence of an albumin–IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis
- (2020) Ako Ishihara et al. Nature Biomedical Engineering
- PROSS 2: a new server for the design of stable and highly expressed protein variants
- (2020) Jonathan Jacob Weinstein et al. BIOINFORMATICS
- An IL-2-grafted antibody immunotherapy with potent efficacy against metastatic cancer
- (2020) Dilara Sahin et al. Nature Communications
- Suppression of Rheumatoid Arthritis by Enhanced Lymph Node Trafficking of Engineered Interleukin‐10 in Murine Models
- (2020) Eiji Yuba et al. Arthritis & Rheumatology
- De novo design of potent and selective mimics of IL-2 and IL-15
- (2019) Daniel-Adriano Silva et al. NATURE
- A Glycoengineered Interferon-β Mutein (R27T) Generates Prolonged Signaling by an Altered Receptor-Binding Kinetics
- (2019) Saehyung Lee et al. Frontiers in Pharmacology
- Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
- (2019) Alberto Mantovani et al. IMMUNITY
- A coiled-coil masking domain for selective activation of therapeutic antibodies
- (2019) Vivian H. Trang et al. NATURE BIOTECHNOLOGY
- Cytokines in Inflammatory Disease
- (2019) Shinwan Kany et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control
- (2019) Zhichen Sun et al. Nature Communications
- Programmable Bivalent Peptide–DNA Locks for pH-Based Control of Antibody Activity
- (2019) Wouter Engelen et al. ACS Central Science
- Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects
- (2018) Kai-Yang Tang et al. Cellular & Molecular Immunology
- Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models
- (2018) Bai Liu et al. CYTOKINE
- Immunomodulatory effects of a rationally designed peptide mimetic of human IFNβ in EAE model of multiple sclerosis
- (2018) Mansour Poorebrahim et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Heterodimeric Fc-fused IL12 shows potent antitumor activity by generating memory CD8+ T cells
- (2018) Keunok Jung et al. OncoImmunology
- The generation and biological activity of a long-lasting recombinant human interferon-λ1
- (2018) Wu-mei Yuan et al. PROTEIN ENGINEERING DESIGN & SELECTION
- The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
- (2017) Juan L. Mendoza et al. IMMUNITY
- Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cells
- (2017) Rodrigo Vazquez-Lombardi et al. Nature Communications
- Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers
- (2017) Ignacio Moraga et al. eLife
- Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines
- (2017) Christian Klein et al. OncoImmunology
- Stimulation of Natural Killer Cell–Mediated Tumor Immunity by an IL15/TGFβ–Neutralizing Fusion Protein
- (2016) Spencer Ng et al. CANCER RESEARCH
- PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
- (2016) Peter L. Turecek et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy
- (2015) Jonathan T. Sockolosky et al. ADVANCED DRUG DELIVERY REVIEWS
- The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes
- (2015) Paul H. Kierstead et al. JOURNAL OF CONTROLLED RELEASE
- Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein
- (2015) Yu Mima et al. MOLECULAR PHARMACEUTICS
- FireProt: Energy- and Evolution-Based Computational Design of Thermostable Multiple-Point Mutants
- (2015) David Bednar et al. PLoS Computational Biology
- Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
- (2014) Mark D. Turner et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- On the biodegradability of polyethylene glycol, polypeptoids and poly(2-oxazoline)s
- (2014) Juliane Ulbricht et al. BIOMATERIALS
- Side Effects of Cytokines Approved for Therapy
- (2014) Brian A. Baldo DRUG SAFETY
- PEGylation Improves the Pharmacokinetic Properties and Ability of Interferon Gamma to Inhibit Growth of a Human Tumor Xenograft in Athymic Mice
- (2014) Christine M. Fam et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Enhanced in vivo efficacy of a long-life type I Interferon superagonist in a mouse model of multiple sclerosis
- (2014) Daniel Harari et al. JOURNAL OF NEUROIMMUNOLOGY
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- Growth Factors Engineered for Super-Affinity to the Extracellular Matrix Enhance Tissue Healing
- (2014) M. M. Martino et al. SCIENCE
- The Role of the Extracellular Matrix Components in Cutaneous Wound Healing
- (2014) Pawel Olczyk et al. Biomed Research International
- Chimera of IL-2 Linked to Light Chain of anti-IL-2 mAb Mimics IL-2/anti-IL-2 mAb Complexes Both Structurally and Functionally
- (2013) Jakub Tomala et al. ACS Chemical Biology
- Albumin as a versatile platform for drug half-life extension
- (2013) Darrell Sleep et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics
- (2013) Timo Rath et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Pharmacokinetics of Peptide–Fc Fusion Proteins
- (2013) W.U. Benjamin et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins
- (2013) M. Schlapschy et al. PROTEIN ENGINEERING DESIGN & SELECTION
- The Role of Changes in Extracellular Matrix of Cartilage in the Presence of Inflammation on the Pathology of Osteoarthritis
- (2013) Maricela Maldonado et al. Biomed Research International
- THE ALBUMIN-BINDING DOMAIN AS A SCAFFOLD FOR PROTEIN ENGINEERING
- (2013) Johan Nilvebrant et al. Computational and Structural Biotechnology Journal
- Fc-fusion proteins: new developments and future perspectives
- (2012) Daniel M. Czajkowsky et al. EMBO Molecular Medicine
- Balancing the Pharmacokinetics and Pharmacodynamics of Interferon-α2b and Human Serum Albumin Fusion Protein by Proteolytic or Reductive Cleavage Increases Its in Vivo Therapeutic Efficacy
- (2012) Hong Liang Zhao et al. MOLECULAR PHARMACEUTICS
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
- (2012) Aron M. Levin et al. NATURE
- Recent Advances on the Role of Cytokines in Atherosclerosis
- (2011) Hafid Ait-Oufella et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- RosettaScripts: A Scripting Language Interface to the Rosetta Macromolecular Modeling Suite
- (2011) Sarel J. Fleishman et al. PLoS One
- Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential
- (2011) Nigel M. Stapleton et al. Nature Communications
- PyRosetta: a script-based interface for implementing molecular modeling algorithms using Rosetta
- (2010) S. Chaudhury et al. BIOINFORMATICS
- The Versatile MHC Class I-related FcRn Protects IgG and Albumin from Degradation: Implications for Development of New Diagnostics and Therapeutics
- (2009) Jan Terje Andersen et al. Drug Metabolism and Pharmacokinetics
- A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
- (2009) Volker Schellenberger et al. NATURE BIOTECHNOLOGY
- High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma
- (2008) Jacob A. Klapper et al. CANCER
- Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C
- (2008) Stefan Zeuzem et al. HEPATOLOGY
- Structural Biology of Shared Cytokine Receptors
- (2007) Xinquan Wang et al. Annual Review of Immunology
- Protein therapeutics: a summary and pharmacological classification
- (2007) Benjamin Leader et al. NATURE REVIEWS DRUG DISCOVERY
- The functions of cytokines and their uses in toxicology
- (2004) John R. Foster INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now